Enovix Corporation (NASDAQ:ENVX - Get Free Report)'s share price shot up 9.4% during trading on Friday. The stock traded as high as $2.97 and last traded at $2.79. 28,768,235 shares were traded during mid-day trading, an increase of 315% from the average daily volume of 6,925,699 shares. The stock had previously closed at $2.55.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on the company. Cantor Fitzgerald restated an "overweight" rating and set a $25.00 price target on shares of Enovix in a report on Thursday, August 13th. Loop Capital upgraded shares of Enovix to a "strong-buy" rating in a research note on Monday, August 17th. Craig Hallum set a $7.00 price objective on shares of Enovix in a research report on Thursday, August 13th. B. Riley Financial reduced their price objective on shares of Enovix from $10.00 to $9.00 and set a "buy" rating for the company in a research note on Thursday, August 13th. Finally, William Blair cut shares of Enovix from an "outperform" rating to a "market perform" rating in a report on Monday, August 17th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $10.77.
Read Our Latest Stock Report on Enovix
Enovix Trading Up 9.4%
The firm has a market capitalization of $612.27 million, a PE ratio of -3.44 and a beta of 2.49. The firm has a 50 day simple moving average of $3.00 and a 200 day simple moving average of $4.94. The company has a current ratio of 9.71, a quick ratio of 9.37 and a debt-to-equity ratio of 2.46.
Enovix (NASDAQ:ENVX - Get Free Report) last posted its quarterly earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.02. The firm had revenue of $9.02 million during the quarter, compared to analysts' expectations of $8.43 million. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%. The company's revenue was up 20.8% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.13) earnings per share. Enovix has set its Q3 2026 guidance at -0.170--0.130 EPS. Equities analysts expect that Enovix Corporation will post -0.79 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Enovix
Hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. bought a new stake in shares of Enovix in the second quarter worth approximately $100,054,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Enovix during the second quarter valued at approximately $8,689,000. Bank of America Corp DE purchased a new stake in Enovix in the second quarter worth approximately $8,356,000. Bank of New York Mellon Corp purchased a new stake in Enovix in the second quarter worth approximately $3,551,000. Finally, Deutsche Bank AG purchased a new stake in Enovix in the second quarter worth approximately $3,343,000. Institutional investors own 50.92% of the company's stock.
About Enovix
(
Get Free Report)
Enovix Corporation is a battery technology company that develops lithium-ion batteries using a silicon-anode architecture. Its approach is designed to increase energy density while maintaining safety and cycle-life characteristics through a three-dimensional cell design and a mechanical constraint system that helps manage silicon expansion during charging.
The company's products are intended for applications that require compact, high-performance power sources, including consumer electronics, wearable devices, Internet of Things equipment, industrial products, and defense and aerospace systems.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.